Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4UMQ

Structure of MELK in complex with inhibitors

4UMQ の概要
エントリーDOI10.2210/pdb4umq/pdb
関連するPDBエントリー4D2T 4D2V 4D2W 4UMP 4UMR 4UMT 4UMU
分子名称MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE, 3-{5-[(3-hydroxy-5-methoxyphenyl)amino]-2-(phenylcarbamoyl)phenoxy}propan-1-aminium (3 entities in total)
機能のキーワードtransferase, fragment based drug design
由来する生物種HOMO SAPIENS (HUMAN)
細胞内の位置Cell membrane ; Peripheral membrane protein : Q14680
タンパク質・核酸の鎖数1
化学式量合計41300.74
構造登録者
主引用文献Johnson, C.N.,Berdini, V.,Beke, L.,Bonnet, P.,Brehmer, D.,Coyle, J.E.,Day, P.J.,Frederickson, M.,Freyne, E.J.E.,Gilissen, R.A.H.J.,Hamlett, C.C.F.,Howard, S.,Meerpoel, L.,Mcmenamin, R.,Patel, S.,Rees, D.C.,Sharff, A.,Sommen, F.,Wu, T.,Linders, J.T.M.
Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase
Acs Med.Chem.Lett., 6:25-, 2015
Cited by
PubMed Abstract: Fragment-based drug design was successfully applied to maternal embryonic leucine zipper kinase (MELK). A low affinity (160 μM) fragment hit was identified, which bound to the hinge region with an atypical binding mode, and this was optimized using structure-based design into a low-nanomolar and cell-penetrant inhibitor, with a good selectivity profile, suitable for use as a chemical probe for elucidation of MELK biology.
PubMed: 25589925
DOI: 10.1021/ML5001245
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.6 Å)
構造検証レポート
Validation report summary of 4umq
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon